"Drug Labeling" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
| Descriptor ID |
D004348
|
| MeSH Number(s) |
E05.916.310 J01.576.655.750.321.400 J01.576.761.300.400
|
| Concept/Terms |
Drug Labeling- Drug Labeling
- Labeling, Drug
- Drug Labelling
- Labelling, Drug
- Package Inserts, Drug
- Drug Package Insert
- Drug Package Inserts
- Insert, Drug Package
- Inserts, Drug Package
- Package Insert, Drug
- Product Labeling, Drug
- Drug Product Labeling
- Labeling, Drug Product
Black Box Warning- Black Box Warning
- Black Box Warnings
- Box Warning, Black
- Box Warnings, Black
- Warning, Black Box
- Warnings, Black Box
- Boxed Warning
- Boxed Warnings
- Warning, Boxed
- Warnings, Boxed
|
Below are MeSH descriptors whose meaning is more general than "Drug Labeling".
Below are MeSH descriptors whose meaning is more specific than "Drug Labeling".
This graph shows the total number of publications written about "Drug Labeling" by people in this website by year, and whether "Drug Labeling" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2010 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Labeling" by people in Profiles.
-
Impact of Food and Drug Administration hepatotoxicity warning on prescribing and monitoring of dronedarone in a tertiary teaching hospital. Int J Pharm Pract. 2015 Dec; 23(6):456-60.
-
The Food and Drug Administration's paternalism. Am J Ther. 2010 Nov-Dec; 17(6):533-4.
-
Composite end points, black box warnings, and allegations of bias. Am J Ther. 2010 May-Jun; 17(3):233.
-
The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol. 2010 Apr; 5(4):553-6.
-
Proposed product labeling changes: does it really matter? Am J Ther. 2001 May-Jun; 8(3):145-6.
-
Are we overregulated? Am J Ther. 2001 Jan-Feb; 8(1):1-2.
-
New label requirements for pediatric medications. Nurs Spectr (Wash D C). 1999 Jun 14; 9(12):16.